Liang Juan-Juan, Zhou Ying-Ying, Wu Jun, Ding Ya
Key Laboratory of Drug Quality Control and Pharmacovigilance, China Pharmaceutical University, Ministry of Education, Nanjing 210009, China.
Curr Drug Metab. 2014;15(6):620-31. doi: 10.2174/1389200215666140605131427.
Gold nanoparticles (AuNPs) have demonstrated increasingly wide applications in drug delivery due to their unique physicochemical and optical properties as well as low toxicity. Compared to the organic nanocarriers for therapeutic agents, AuNPs have shown superior performance as drug delivery vectors, including the inert nature, well-developed synthesis strategies, tunable size, and flexible and easy surface modification with various chemical and biological molecules. In this review, we emphasize on the applications of AuNPs in the aspect of improving pharmaceutical property and therapeutic efficacy of drugs, especially those covalently and noncovalently connected to the surface of AuNPs. Acting as a solid core to link drugs and their derivatives, AuNPs provide the nano-prodrug system with compressed size, high loading efficiency, three-dimension structure, and enhanced cellular uptake capability. With the intensive and systematical investigation of the drug-connected AuNPs, several important issues will become the hot but emergent topics for future research in this field, such as the toxicity in live human subjects, ultimate destination, and possible pathways and mechanisms for their absorption, circulation, distribution, metabolism, and excretion.
金纳米颗粒(AuNPs)由于其独特的物理化学和光学性质以及低毒性,在药物递送方面已展现出越来越广泛的应用。与用于治疗剂的有机纳米载体相比,AuNPs作为药物递送载体表现出卓越的性能,包括惰性本质、成熟的合成策略、可调节的尺寸以及能够灵活且容易地用各种化学和生物分子进行表面修饰。在本综述中,我们着重介绍AuNPs在改善药物的药学性质和治疗效果方面的应用,特别是那些与AuNPs表面共价和非共价连接的药物。作为连接药物及其衍生物的固体核心,AuNPs为纳米前药系统提供了紧凑的尺寸、高负载效率、三维结构以及增强的细胞摄取能力。随着对连接药物的AuNPs进行深入且系统的研究,若干重要问题将成为该领域未来研究的热点但紧迫的课题,例如在活体人类受试者中的毒性、最终归宿以及它们吸收、循环、分布、代谢和排泄的可能途径和机制。
Curr Drug Metab. 2014
Crit Rev Ther Drug Carrier Syst. 2024
J Control Release. 2010-6-11
Curr Pharm Des. 2017
Adv Drug Deliv Rev. 2011-9-6
Int J Pharm. 2015-2-18
Arch Pharm Res. 2013-11-12
Nanoscale Adv. 2023-11-17
Nanomaterials (Basel). 2021-8-25
Front Bioeng Biotechnol. 2020-1-31
Nanobiomedicine (Rij). 2018-10-11